Abstract The effectiveness of immunotherapy against glioblastoma (GBM) remains limited, suggesting that antigen-specific tumor-infiltrating lymphocytes (TILs) are rare. This study aimed to identify tumor-specific T cells in GBM as the basis for antigen-specific immunotherapy. Tumor specimens were collected from 56 patients newly diagnosed with IDH-wildtype GBM.
Chin Tan
Get in touch with Chin
Contact Chin, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack